Eye drops containing a derivative of turmeric reduce the loss of retinal cells in rats, finds a new study led by UCL and Imperial College London researchers.
Loss of these cells is known to be an early sign of glaucoma and the eye drops could in time be a new treatment option for the condition.
In the new Scientific Reports paper, the researchers report a new method to deliver curcumin, extracted from the yellow spice turmeric, directly to the back of the eye using eye drops, overcoming the challenge of curcumin’s poor solubility.
They are also investigating how the eye drops could be used as a diagnostic tool for a range of conditions.
“Curcumin is an exciting compound that has shown promise at detecting and treating the neurodegeneration implicated in numerous eye and brain conditions from glaucoma to Alzheimer’s disease, so being able to administer it easily in eye drops may end up helping millions of people,” said the study’s lead author, Professor Francesca Cordeiro (UCL Institute of Ophthalmology, Western Eye Hospital and Imperial College London).
Glaucoma is a group of eye conditions affecting over 60 million people worldwide that leads to irreversible blindness in 1 in 10 cases. The condition mainly involves the loss of retinal ganglion cells, a type of neuron located near the surface of the retina. Stopping the loss of these cells early on has not yet been achieved, so it is a key focus of glaucoma research.
Curcumin has previously been shown to protect retinal ganglion cells when administered orally. For the current study, the researchers were seeking to find a more reliable method to deliver curcumin. Oral administration is difficult because curcumin has poor solubility, so it does not easily dissolve and get absorbed into the bloodstream, and would require people to take large amounts of tablets (up to 24 a day) that may cause gastrointestinal side effects.
The team developed a novel nanocarrier, wherein the curcumin is contained within a surfactant combined with a stabiliser, both of which are known to be safe for human use and are already in existing eye products. The nanocarrier can be used in eye drops to deliver much higher loads of curcumin than other products in development, increasing the drug’s solubility by a factor of almost 400,000, and localises the curcumin in the eyes instead of throughout the body.
The researchers initially tested the product on cells that are used to model glaucoma, before conducting trials in rats with eye conditions involving the loss of retinal ganglion cells.
After twice-daily use of eye drops in the rats for three weeks, retinal ganglion cell loss was significantly reduced compared to matched controls, and the treatment was found to be well-tolerated with no signs of eye irritation or inflammation.
Having found an effective way to deliver curcumin, the researchers are hopeful that it could also be used to diagnose Alzheimer’s disease, as curcumin is known to bind to the amyloid beta protein deposits implicated in Alzheimer’s, and can be detected in the retina with fluorescence to highlight the malignant proteins.
“We are now researching diagnostic uses for these eye drops alongside other ways to visualise the retina, as eye tests can be an opportunity to detect signs of neurodegeneration with a simple, non-invasive test,” said co-lead author Dr Ben Davis (UCL Institute of Ophthalmology and Imperial College London).
Professor Cordeiro added: “As we live longer, diseases such as glaucoma and Alzheimer’s are steadily increasing. We believe our findings could make a major contribution at helping the lives of people affected by these devastating diseases.”
Receive an email update when we add a new GLAUCOMA article.
The Latest on: Glaucoma
via Google News
The Latest on: Glaucoma
- Nicox teams up with Chinese firm to develop and sell glaucoma drug on December 16, 2018 at 10:38 pm
PARIS (Reuters) - French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nic... […]
- Nicox and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize NCX 470 in the Chinese market on December 16, 2018 at 10:32 pm
"Ocumension is focused on bringing novel ophthalmic therapeutics to the Chinese market, and so we welcome the opportunity to partner with Nicox, one of the leading R&D companies in the glaucoma ... […]
- EHR-linked reminder system for glaucoma meds perceived useful on December 14, 2018 at 12:22 pm
(HealthDay)—Patients with glaucoma generally find an electronic health record (EHR)-linked reminder system for glaucoma medications useful, according to a study published online Dec. 13 in JAMA ... […]
- Glaucoma Therapeutics Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis and Forecast to 2021 on December 12, 2018 at 5:28 pm
The Glaucoma Therapeutics Market report 2018 studies the growing market trends, technological developments & growth opportunities in the Glaucoma Therapeutics Market space. Key Glaucoma Therapeutics m... […]
- Researcher Receives Second Patent for Device to Provide Relief from Glaucoma on December 12, 2018 at 2:01 pm
Khalid Lafdi, University of Dayton Wright Brothers Endowed Chair in Nanomaterials, was named on a second patent for a medical drainage device mainly for glaucoma patients that also could be used for d... […]
- Glaucoma Treatment market forecast 2018 – 2023 available in new report on December 12, 2018 at 6:54 am
Scope of the Report: The global Glaucoma Treatment market is valued at million in 2017 and is expected to reach million by the end of 2023, growing at a CAGR of between 2017 and 2023. The Asia-Pacific ... […]
- 52 Year Old Abuja Man Reveals Herbal Remedy that Improves Eyesight, Reverses Glaucoma and cataract without surgery on December 9, 2018 at 3:34 am
If you’re tired of struggling with poor eyesight, specifically someone who wants to improve their vision, reverse glaucoma, cataract, near-sightedness and wants to stop using glasses, then here is goo... […]
- Foods That May Help To Lower Risk Of Glaucoma on December 6, 2018 at 8:18 pm
Glaucoma can lead to incurable blindness, unfortunately there are no early warning signs and half of the people with glaucoma don’t even know they have it. Simple changes in diet can help you to cut y... […]
- Glaucoma: How to avoid, survive loss of sight on December 5, 2018 at 6:12 pm
AS often said, ‘in the land of the blind, a one-eyed man is king.’ Similarly, in the land of the sighted, every man is king. It goes to say the eye is a reverend organ in the body, a sense ... […]
via Bing News